# BreezeBio (formerly GenEdit)

**Canonical:** https://apis.io/providers/geneditbio/  
**Website:** https://breezebio.com  
**APIs profiled:** 0

BreezeBio, Inc. (formerly GenEdit) is a clinical-stage genetic medicines company based in South San Francisco, California, solving the central delivery problem of gene editing and genetic medicine. Its proprietary NanoGalaxy platform is a library of thousands of non-viral, non-lipid polymer nanoparticles engineered to deliver genetic payloads (mRNA, DNA, and CRISPR ribonucleoprotein) to specific cell types and tissues without triggering an immune response. The company is advancing an internal pipeline of precision genetic medicines focused on autoimmune disease and oncology, led by BRZ-101, a tolerance-inducing candidate for Type 1 diabetes. GenEdit rebranded to BreezeBio in February 2026 alongside a $60M Series B, and has established platform partnerships with Roche's Genentech and Sarepta Therapeutics. This is a therapeutics company with no public developer API, SDK, or developer portal; the profile captures its identity and domain-security posture.

## Kin Score — 7.6 / 100 (minimal)

Scored 2026-08-21 under rubric 0.12.0. Trend: flat (+0.0 from 7.6).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 7.1 |
| Commercial Clarity | 10.5 |
| Access Clarity | 10.5 |

Regulatory layer — **Health**: 12.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Geneditbio Domain Security** — TLSv1.3

## Tags

Company, Biotechnology, Genetic Medicine, Gene Editing, Drug Delivery, Nanoparticles, CRISPR, Therapeutics, Life Sciences, Healthcare

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/geneditbio/). Scores are computed from the provider's own public artifacts under a published rubric.